365 related articles for article (PubMed ID: 7269848)
1. [Investigations on the dependency of hemagglutination inhibition titers against rubella virus on the number and quality of antibody molecules (author's transl)].
Hoppe G
Zentralbl Bakteriol A; 1981; 249(2):143-51. PubMed ID: 7269848
[TBL] [Abstract][Full Text] [Related]
2. [Investigations on strain-specific differences in the relationship between hemagglutination-inhibition titers and the number and quality of antibody molecules oriented to influenza virus type A strains (author's transl)].
Kuschel K; Drescher J
Zentralbl Bakteriol Orig A; 1978; 242(3):315-26. PubMed ID: 746994
[TBL] [Abstract][Full Text] [Related]
3. Persistence of antibody titers after vaccination with rubella virus vaccine ("Cendehill" strain).
Peetermans J; du Pan RM; Huygelen C
Dev Biol Stand; 1979; 43():361-5. PubMed ID: 520683
[TBL] [Abstract][Full Text] [Related]
4. [Changes in antibody titre after rubella vaccination in primarily rubella-sera positive parturient women. Demonstration of antigen-specific (rubella) and non-specific stimulated antibody titres (author's transl)].
Doerr HW; Geisen HP; Kapp M; Schmidt W
Dtsch Med Wochenschr; 1980 Sep; 105(38):1316-20. PubMed ID: 6257468
[No Abstract] [Full Text] [Related]
5. Susceptibility to rubella and borderline immunity.
Fogel A; Barnea B; Gerichter CB
Isr J Med Sci; 1983 Oct; 19(10):934-5. PubMed ID: 6363349
[TBL] [Abstract][Full Text] [Related]
6. [Prepuberal rubella vaccination and development of antibodytiters during five years (author's transl)].
Müller G; Baumann H
Padiatr Padol; 1978; 13(3):291-7. PubMed ID: 673433
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of HI antibody titer against rubella virus to determine the effect of mass vaccination in Tehran.
Soleimanjahi H; Bamdad T; Fotouhi F; Roustai MH; Faghihzadeh S
J Clin Virol; 2005 Oct; 34(2):153-4. PubMed ID: 16076562
[TBL] [Abstract][Full Text] [Related]
8. [Immune status of a school-population sample 5 years after antirubella vaccination].
Quaglio P; Dattoli A; Mantovani G
G Batteriol Virol Immunol; 1982; 75(7-12):233-8. PubMed ID: 7188256
[TBL] [Abstract][Full Text] [Related]
9. Rubella antibodies in women of childbearing age during an epidemic and the two years thereafter.
Hornstein L; Ben-Porath E
Isr J Med Sci; 1976 Oct; 12(10):1189-93. PubMed ID: 990135
[TBL] [Abstract][Full Text] [Related]
10. Rubella immunity measured by hemagglutination inhibition and enzyme-linked immunosorbent assay.
Hornstein L; Swartz TA; Heimann M
Isr J Med Sci; 1985 Aug; 21(8):666-9. PubMed ID: 4044233
[TBL] [Abstract][Full Text] [Related]
11. Study of young women vaccinated against rubella virus for 10 years in Taiwan.
Lin DB; Kao CL; Lee CY
Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):707-14. PubMed ID: 9253871
[TBL] [Abstract][Full Text] [Related]
12. [Antibody response to live rubella vaccination and its clinical meanings].
Hoshiba T; Yabuki Y; Asamoto A; Kimura N; Tanaka J
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):2029-35. PubMed ID: 3429985
[TBL] [Abstract][Full Text] [Related]
13. Studies on live rubella vaccine. VI. Seroepidemiological surveillance and immunization of adolescents in high school.
Minekawa Y; Takahashi M; Ueda S; Ogino T
Biken J; 1975 Sep; 18(3):149-54. PubMed ID: 1191245
[TBL] [Abstract][Full Text] [Related]
14. Comparison of different methods for assessment of rubella infection and immunity.
Braun R; Hornig C; Sann G; Doerr HW
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Sep; 252(4):431-7. PubMed ID: 6758420
[TBL] [Abstract][Full Text] [Related]
15. Positive rates for rubella antibody in pregnant women and benefit of post-partum vaccination in a Japanese perinatal center.
Okuda M; Yamanaka M; Takahashi T; Ishikawa H; Endoh M; Hirahara F
J Obstet Gynaecol Res; 2008 Apr; 34(2):168-73. PubMed ID: 18412777
[TBL] [Abstract][Full Text] [Related]
16. Description of a technique for the determination of the concentration and quality of rubella virus antibody molecules and experience with testing sera from humans with recent and past rubella infection.
Hoppe G; Drescher J
Arch Virol; 1980; 65(2):109-21. PubMed ID: 7425853
[TBL] [Abstract][Full Text] [Related]
17. Rubella immunity: comparison of hemagglutination inhibition and radioimmunoassay antibody methods.
Harris RE; Smith KO; Gehle WD; Dupuy HJ
Obstet Gynecol; 1980 May; 55(5):603-7. PubMed ID: 7366918
[TBL] [Abstract][Full Text] [Related]
18. Rubella specific cell-mediated and humoral immunity following vaccination in college students with low antibody titers.
Terada K; Itoh Y; Wakabayashi T; Teranishi H; Akaike H; Ogita S; Ouchi K
Vaccine; 2015 Nov; 33(45):6093-8. PubMed ID: 26275479
[TBL] [Abstract][Full Text] [Related]
19. [Reasons for repeated serologically unsuccessful (HAI-HIG test) rubella vaccination (author's transl)].
Ehrengut W; Florent G
Dtsch Med Wochenschr; 1981 Jul; 106(31-32):987-9. PubMed ID: 7261921
[TBL] [Abstract][Full Text] [Related]
20. Specificity of the passive hemagglutination test for antibody to rubella virus and the passive hemagglutination response after vaccination.
Cremer NE; Hagens SJ; Cossen CK
J Clin Microbiol; 1981 Jan; 13(1):226-7. PubMed ID: 7462415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]